Manar G. Helal, “Empagliflozin attenuates cyclophosphamide-induced hepatotoxicity via targeting Nrf2/HO-1 signaling, oxidative stress, and inflammation”, World J Pharm Sci, vol. 7, no. 11, pp. 49–59, Nov. 2019.